Display options
Cite
Lam AK, Bourke MJ, Chen R, et al. Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2021;114:54-65doi: 10.1016/j.humpath.2021.05.003.
Lam, A. K., Bourke, M. J., Chen, R., Fiocca, R., Fujishima, F., Fujii, S., Jansen, M., Kumarasinghe, P., Langer, R., Law, S., Meijer, S. L., Muldoon, C., Novelli, M., Shi, C., Tang, L., & Nagtegaal, I. D. (2021). Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. Human pathology, 11454-65. https://doi.org/10.1016/j.humpath.2021.05.003
Lam, Alfred K, et al. "Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting." Human pathology vol. 114 (2021): 54-65. doi: https://doi.org/10.1016/j.humpath.2021.05.003
Lam AK, Bourke MJ, Chen R, Fiocca R, Fujishima F, Fujii S, Jansen M, Kumarasinghe P, Langer R, Law S, Meijer SL, Muldoon C, Novelli M, Shi C, Tang L, Nagtegaal ID. Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2021 Aug;114:54-65. doi: 10.1016/j.humpath.2021.05.003. Epub 2021 May 13. PMID: 33992659.
Copy Download .nbib Format: NLM
Share it on

Hum Pathol. 2021 Aug;114:54-65. doi: 10.1016/j.humpath.2021.05.003. Epub 2021 May 13.

Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer Reporting.

Human pathology

Alfred K Lam, Michael J Bourke, Renyin Chen, Roberto Fiocca, Fumiyoshi Fujishima, Satoshi Fujii, Marnix Jansen, Priyanthi Kumarasinghe, Rupert Langer, Simon Law, Sybren L Meijer, Cian Muldoon, Marco Novelli, Chanjuan Shi, Laura Tang, Iris D Nagtegaal

Affiliations

  1. Pathology, School of Medicine and Dentistry, Gold Coast Campus, Griffith University, Gold Coast, Queensland, 4222, Australia; Pathology Queensland, Gold Coast University Hospital, Southport, Queensland, 4222, Australia; Faculty of Medicine, The University of Queensland, Herston, Queensland, 4006, Australia. Electronic address: [email protected].
  2. Westmead Hospital, Department of Gastroenterology and Hepatology, Sydney, New South Wales, 2145, Australia; University of Sydney, Westmead Clinical School, Sydney, New South Wales, 2145, Australia. Electronic address: [email protected].
  3. Department of Pathology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, Henan Province, PR China. Electronic address: [email protected].
  4. Department of Pathology, University of Genova and IRCCS Policlinico San Martino, 16132, Genova, Italy. Electronic address: [email protected].
  5. Department of Pathology, Tohoku University Hospital, Aoba-ku, Sendai, 980-8574, Japan. Electronic address: [email protected].
  6. Department of Molecular Pathology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan; Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital East, Kashiwa, 6-5-1, Japan. Electronic address: [email protected].
  7. University College London (UCL) Cancer Institute, London, United Kingdom; University College London Hospitals NHS Trust, London, WC1E 6DD, United Kingdom. Electronic address: [email protected].
  8. PathWest Laboratory Medicine, PathWest QEII Medical Centre, Perth, 6009, Western Australia, Australia. Electronic address: [email protected].
  9. Institute of Pathology, University of Bern, 3012 Bern, Switzerland. Electronic address: [email protected].
  10. Queen Mary Hospital, The University of Hong Kong, Hong Kong, China. Electronic address: [email protected].
  11. Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, 1105, AZ, the Netherlands. Electronic address: [email protected].
  12. Histopathology Department, St James's Hospital, Dublin, D08 NHY1, Ireland. Electronic address: [email protected].
  13. Research Department of Pathology, University College London Medical School, London, WC1E 6DD, United Kingdom. Electronic address: [email protected].
  14. Department of Pathology, Duke University School of Medicine, Durham, NC, 27708, United States. Electronic address: [email protected].
  15. Department of Pharmacy, Memorial Sloan Kettering Cancer Centre, New York City, NY, 10065, United States. Electronic address: [email protected].
  16. Department of Pathology, Radboud University Medical Centre, Nijmegen, 6500, the Netherlands. Electronic address: [email protected].

PMID: 33992659 DOI: 10.1016/j.humpath.2021.05.003

Abstract

BACKGROUND AND OBJECTIVES: A standardized data set for esophageal carcinoma pathology reporting was developed based on the approach of the International Collaboration on Cancer Reporting (ICCR) for the purpose of improving cancer patient outcomes and international benchmarking in cancer management.

MATERIALS AND METHODS: The ICCR convened a multidisciplinary international expert panel to identify the best evidence-based clinical and pathological parameters for inclusion in the data set for esophageal carcinoma. The data set incorporated the current edition of the World Health Organization Classification of Tumours of the Digestive System, and Tumour-Node-Metastasis staging systems.

RESULTS: The scope of the data set encompassed resection specimens of the esophagus and esophagogastric junction with tumor epicenter ≤20 mm into the proximal stomach. Core reporting elements included information on neoadjuvant therapy, operative procedure used, tumor focality, tumor site, tumor dimensions, distance of tumor to resection margins, histological tumor type, presence and type of dysplasia, tumor grade, extent of invasion in the esophagus, lymphovascular invasion, response to neoadjuvant therapy, status of resection margin, ancillary studies, lymph node status, distant metastases, and pathological staging. Additional non-core elements considered useful to report included clinical information, specimen dimensions, macroscopic appearance of tumor, and coexistent pathology.

CONCLUSIONS: This is the first international peer-reviewed structured reporting data set for surgically resected specimens of the esophagus. The ICCR carcinoma of the esophagus data set is recommended for routine use globally and is a valuable tool to support standardized reporting, to benefit patient care by providing diagnostic and prognostic best-practice parameters.

Copyright © 2021 Elsevier Inc. All rights reserved.

Keywords: Carcinoma; Data set; Esophagus; International Collaboration onCancer Reporting; Pathology; Structured report

Publication Types